My watch list  

Myasthenia Gravis

News Myasthenia Gravis

  • Explaining why myasthenia patients relapse after treatment

    A new Yale-led study helps explain why some myasthenia gravis (MG) patients relapse after initially responding to a drug called rituximab, commonly used to treat the incurable autoimmune disease marked by muscle weakness and fatigue. In patients with MG, B cells — a subset of white cells that produc more

  • First crystal model of under-diagnosed autoimmune disease

    As a molecular biologist, Kaori Noridomi gets an up-close view of the targets of her investigations. But when she began studying the molecular structures of a rarely diagnosed autoimmune disorder, myasthenia gravis, she decided to step out of the lab for a better view. Noridomi said she thought she more

  • New technique for testing drugs to treat cystic fibrosis and epilepsy

    Researchers from the University of Southampton, in collaboration with researchers at the University of Quebec at Montreal, have developed a new microsystem for more efficient testing of pharmaceutical drugs to treat diseases such as cystic fibrosis, MG (myasthenia gravis) and epilepsy. A large perce more

All news on myasthenia gravis

Publications Myasthenia Gravis

All publications on myasthenia gravis

Myasthenia gravis

Myasthenia gravis Myasthenia gravis (literally "serious muscle-weakness"; from Greek μύς "muscle", "weakness", and Latin gravis "serious"; abbreviated MG) is a neuromuscular disease leading to fluctuating muscle weakness and fatiguability ... more


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE